Bioiberica, the world’s leading manufacturer of heparin API, is part of the SARIA Group. Heparin is the most commonly used anticoagulant drug worldwide and is utilised in the prevention and treatment of thrombosis, among other applications. It has been on the WHO’s essential medicines list since 1977. In addition, Bioiberica produces many other active ingredients for pharmaceutical and nutraceutical applications, including the treatment of joint problems and thyroid disorders. All products are based on biomolecules of animal origin and are 100 per cent organic. Full traceability and comprehensive quality control are guaranteed throughout the production process.